Smith V - Search Results

1

Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee.

Okosieme O, Gilbert J, Abraham P, Boelaert K, Dayan C, Gurnell M, Leese G, McCabe C, Perros P, Smith V, Williams G, Vanderpump M. Okosieme O, et al. Among authors: smith v. Clin Endocrinol (Oxf). 2016 Jun;84(6):799-808. doi: 10.1111/cen.12824. Epub 2015 Jun 25. Clin Endocrinol (Oxf). 2016. PMID: 26010808 Free article. Review.

2

PTTG and PBF repress the human sodium iodide symporter.

Boelaert K, Smith VE, Stratford AL, Kogai T, Tannahill LA, Watkinson JC, Eggo MC, Franklyn JA, McCabe CJ. Boelaert K, et al. Among authors: smith ve. Oncogene. 2007 Jun 28;26(30):4344-56. doi: 10.1038/sj.onc.1210221. Epub 2007 Feb 5. Oncogene. 2007. PMID: 17297475

3

Monocarboxylate transporter 8 in neuronal cell growth.

James SR, Franklyn JA, Reaves BJ, Smith VE, Chan SY, Barrett TG, Kilby MD, McCabe CJ. James SR, et al. Among authors: smith ve. Endocrinology. 2009 Apr;150(4):1961-9. doi: 10.1210/en.2008-1031. Epub 2008 Nov 20. Endocrinology. 2009. PMID: 19022891

4

A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer.

Smith VE, Read ML, Turnell AS, Watkins RJ, Watkinson JC, Lewy GD, Fong JC, James SR, Eggo MC, Boelaert K, Franklyn JA, McCabe CJ. Smith VE, et al. J Cell Sci. 2009 Sep 15;122(Pt 18):3393-402. doi: 10.1242/jcs.045427. Epub 2009 Aug 25. J Cell Sci. 2009. PMID: 19706688 Free PMC article.

5

Pituitary tumor transforming gene binding factor: a new gene in breast cancer.

Watkins RJ, Read ML, Smith VE, Sharma N, Reynolds GM, Buckley L, Doig C, Campbell MJ, Lewy G, Eggo MC, Loubiere LS, Franklyn JA, Boelaert K, McCabe CJ. Watkins RJ, et al. Cancer Res. 2010 May 1;70(9):3739-49. doi: 10.1158/0008-5472.CAN-09-3531. Epub 2010 Apr 20. Cancer Res. 2010. PMID: 20406982 Free PMC article.

6

Pituitary tumor-transforming gene and its binding factor in endocrine cancer.

Smith VE, Franklyn JA, McCabe CJ. Smith VE, et al. Expert Rev Mol Med. 2010 Dec 3;12:e38. doi: 10.1017/S1462399410001699. Expert Rev Mol Med. 2010. PMID: 21129230 Review.

7

Expression and function of the novel proto-oncogene PBF in thyroid cancer: a new target for augmenting radioiodine uptake.

Smith VE, Franklyn JA, McCabe CJ. Smith VE, et al. J Endocrinol. 2011 Aug;210(2):157-63. doi: 10.1530/JOE-11-0064. Epub 2011 Mar 30. J Endocrinol. 2011. PMID: 21450804 Review.

8

Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment.

Read ML, Lewy GD, Fong JC, Sharma N, Seed RI, Smith VE, Gentilin E, Warfield A, Eggo MC, Knauf JA, Leadbeater WE, Watkinson JC, Franklyn JA, Boelaert K, McCabe CJ. Read ML, et al. Cancer Res. 2011 Oct 1;71(19):6153-64. doi: 10.1158/0008-5472.CAN-11-0720. Epub 2011 Aug 15. Cancer Res. 2011. PMID: 21844185 Free PMC article.

9

The pituitary tumor transforming gene in thyroid cancer.

Lewy GD, Sharma N, Seed RI, Smith VE, Boelaert K, McCabe CJ. Lewy GD, et al. Among authors: smith ve. J Endocrinol Invest. 2012 Apr;35(4):425-33. doi: 10.3275/8332. Epub 2012 Apr 5. J Endocrinol Invest. 2012. PMID: 22522436 Review.

10

PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8.

Smith VE, Read ML, Turnell AS, Sharma N, Lewy GD, Fong JC, Seed RI, Kwan P, Ryan G, Mehanna H, Chan SY, Darras VM, Boelaert K, Franklyn JA, McCabe CJ. Smith VE, et al. Endocrinology. 2012 Jul;153(7):3526-36. doi: 10.1210/en.2011-2030. Epub 2012 Apr 25. Endocrinology. 2012. PMID: 22535767

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,772 results

Search Page